Literature DB >> 7975836

HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992.

R Pyhälä1, V Kumpulainen, S Alanko, T Forsten.   

Abstract

Volunteers were immunized once, twice or three times in 1990-1992 with commercial trivalent inactivated influenza vaccine and monitored for haemagglutination inhibition (HI) antibodies. The antibodies that already existed when the subjects entered the study derived from natural infections. Immunizations in the second and third years were necessary to maintain the geometric mean titres of antibody and protection rates at the level recorded after the first vaccination. Negative correlations between prevaccination antibody titres and mean fold antibody increases were noted in most instances analysed. Moreover, at each individual prevaccination titre level the mean fold antibody increases and even postvaccination mean titres were higher after the first than after subsequent vaccinations, suggesting that the HI antibody responses might be affected by vaccine-induced pre-existing antibody more than by the same titres of antibody derived from natural infections. This was most obvious for antibody to the H1N1 subtype virus, A/Finland/164/91. In immunization with B/Yamagata/16/88, anamnestic response of antibody to B/Finland/150/90, which belongs to the antigenically distinct lineage of B/Victoria/2/87-like viruses, was more frequent in the first than in subsequent years. This is in contrast to homologous antibodies, which increased significantly after the second vaccination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975836     DOI: 10.1016/0264-410x(94)90039-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

1.  The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Bonnie B Blomberg
Journal:  Vaccine       Date:  2016-04-20       Impact factor: 3.641

2.  Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.

Authors:  Satoshi Hiroi; Saeko Morikawa; Keiko Nakata; Akiko Maeda; Tsuneji Kanno; Shin Irie; Satoko Ohfuji; Yoshio Hirota; Tetsuo Kase
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.

Authors:  J J Goronzy; J W Fulbright; C S Crowson; G A Poland; W M O'Fallon; C M Weyand
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.

Authors:  Sarah F Andrews; Kaval Kaur; Noel T Pauli; Min Huang; Yunping Huang; Patrick C Wilson
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

Review 5.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

6.  A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.

Authors:  Emilia Nunzi; Anna Maria Iorio; Barbara Camilloni
Journal:  Hum Vaccin Immunother       Date:  2017-09-18       Impact factor: 3.452

7.  Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine.

Authors:  Ekaterina Moroz; Randy A Albrecht; Brandon Aden; Ann Bordwine Beeder; Jianda Yuan; Adolfo García-Sastre; Brian R Edlin; Mirella Salvatore
Journal:  Vaccine       Date:  2016-02-06       Impact factor: 3.641

Review 8.  Humoral immune response to influenza vaccination in patients from high risk groups.

Authors:  L B Brydak; M Machala
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

9.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.

Authors:  Mark G Thompson; Allison Naleway; Alicia M Fry; Sarah Ball; Sarah M Spencer; Sue Reynolds; Sam Bozeman; Min Levine; Jacqueline M Katz; Manjusha Gaglani
Journal:  Vaccine       Date:  2016-02-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.